IRF5 and neoplasm: In murine models of ovarian cancer, melanoma, and glioblastoma, the IRF5/IKKβ NPs localized within tumor sites, where they reprogrammed TAMs, reduced M2 macrophage presence, and increased inflammatory cytokine production.